The remote heating of iron oxide nanoparticles in an alternating magnetic field is used to drive a thermoresponsive sol-gel block copolymer, Pluronic® F-127, through the upper phase transition temperature. This phase change triggers an accelerated release rate of a model drug. Actuation and return to baseline levels are demonstrated for multiple AMF doses.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/adhm.201100013 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!